Huge congratulations to Cheri Ackerman, Jared Kehe, and the whole Concerto Biosciences team. Having participated in our inaugural 2019 Activator Program, we're immensely proud to see Concerto Biosciences making such impactful progress, and of course to have played a small role in your ongoing and evolving story! On behalf of Nucleate, we wish you all the best!
Drumroll please! Concerto Biosciences has officially secured an open Investigational New Drug (IND) application for Ensemble No.2 (ENS-002) First-In-Human clinical trials. In the biotech world, this is a pivotal moment, not only showcasing our technical rigor, but also representing a huge step toward improving patient lives with microbial treatments. Next stop: the clinic! https://lnkd.in/ek3BTYSk
